Replies to post #274902 on Innovation Pharmaceuticals Inc (IPIX)

[LIVED]

Sorry page 100 P186

[Empiricst1]

Zroypu, I stand in awe, how in the ---- did you find this reference. More primo dd.

[williamssc]

Google Translation- KEVETRIN TO ALTER THE TRANSCRIPTIONAL METHODS AND METABOLISM IN CELL LEUKEMIA OF ACUTE MIELOID

Kevetrin is mentioned in this dated Oct 7-9/2019. Just don't understand Italian, but Kevetrin is at P186. K.Menon name is there.

https://www.sie2019.com/timetable.pdf

Good find thanks.

[TheDane]

I only see 63 pages.

[zandant]

Interesting, Z and thanks for the link.

The event is for the Italian Society of Hematology to "review the progress and results of the discipline" and the conference/Congress is held every two years.

Looks like the k piece is a discussion poster which I assume is basically a written scientific paper that the conference attendees can view, in this case during a particular session. https://en.wikipedia.org/wiki/Poster_session)

As noted in Lemon's link, there was a similar conference held in Madrid in 2017 put on by the European Hematology Association where a discussion poster involving K was likewise presented.(https://library.ehaweb.org/eha/2017/22nd/180680/roberta.napolitano.kevetrin.preclinical.study.of.a.new.compound.in.acute.html) The 2017 and 2019 discussion poster titles seem similar - focusing on K and acute myeloid leukemia - and many of the authors are the same but there are additional authors in the 2019 discussion poster. Not sure what to make of that but perhaps further work has been done since 2017 and these additional authors have contributed to the work.

Perhaps Leo can shed some light on the issue if there is any light to be shed.